GlycoMimetics
Utility Patents

Last updated:

List of all GlycoMimetics patents 9 in total

Status Patent
Grant
Utility: Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4 External link
Filling date: 26 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: E-selectin antagonist compounds, compositions, and methods of use External link
Filling date: 26 Sep 2025 Issue date: 17 May 2022
Grant
Utility: Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin External link
Filling date: 26 Sep 2025 Issue date: 5 Apr 2022
Grant
Utility: Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists External link
Filling date: 26 Sep 2025 Issue date: 14 Dec 2021
Grant
Utility: Highly potent multimeric e-selectin antagonists External link
Filling date: 26 Sep 2025 Issue date: 27 Jul 2021
Grant
Utility: Glycomimetic inhibitors of PA-IL and PA-IIL lectins External link
Filling date: 26 Sep 2025 Issue date: 29 Jun 2021
Grant
Utility: E-selectin antagonist compounds, compositions, and methods of use External link
Filling date: 26 Sep 2025 Issue date: 8 Sep 2020
Grant
Utility: E-selectin antagonist compounds, compositions, and methods of use External link
Filling date: 26 Sep 2025 Issue date: 7 Jan 2020
Grant
Utility: Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors External link
Filling date: 26 Sep 2025 Issue date: 31 Dec 2019

Showing 1 to 9 of 9 patents.